News
One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition that can lead to sudden vision loss due to lack of blood flow.
Eli Lilly has rolled out a prefilled pen version of its weight-loss drug Mounjaro at the same price as vials, aiming to ...
There is zero evidence that semaglutides can increase the size of your crown jewels. What may happen is that as you lose ...
Perfect storm to hit Obamacare: Millions of Americans could see insurance premiums surge 75% in 2026
Surging medical costs, pricey new drugs, and the looming end of enhanced subsidies could push ACA Marketplace premiums to ...
In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...
Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing ...
Compelling new ARD-201 preclinical data informs optimized Phase 2 clinical development strategy of obesity programs: Phase 2 POWER trial of oral ARD-201 to focus on weight rebound in patients ...
Oikos Fusion offers a nutrient-dense dairy drink designed to support muscle mass and digestive health during weight loss ...
The North Carolina Department of Health and Human Services will slash Medicaid spending by $319 million effective October 1, ...
Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its ...
Last and least, I look at the drug stocks and I can’t believe how awful they really are, with now Eli Lilly last joining the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results